Deutsche Bank Ag\ Champions Oncology, Inc. Transaction History

Deutsche Bank Ag\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$8.45 - $11.72 $34,890 - $48,391	-4,129 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$10.61 - $13.75 $4,233 - $5,486	-399 Reduced 8.81%	4,129 $46,000
Q4 2020 Feb 16, 2021	BUY	$8.39 - $13.27 $7,173 - $11,345	855 Added 23.28%	4,528 $49,000
Q3 2020 Nov 12, 2020	BUY	$7.05 - $10.2 $2,481 - $3,590	352 Added 10.6%	3,673 $34,000
Q2 2020 Aug 13, 2020	BUY	$6.65 - $9.84 $22,084 - $32,678	3,321 New	3,321 $32,000
Q1 2019 May 15, 2019	SELL	$7.89 - $12.23 $79,689 - $123,523	-10,100 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.29 - $15.27 $474,921 - $994,794	-65,147 Reduced 86.58%	10,100 $78,000
Q3 2018 Nov 14, 2018	BUY	$5.82 - $17.47 $338,415 - $1.02 Million	58,147 Added 340.04%	75,247 $1.31 Million
Q2 2018 Aug 14, 2018	BUY	$3.6 - $7.27 $61,560 - $124,316	17,100 New	17,100 $108,000
Q1 2018 May 15, 2018	SELL	$3.39 - $4.39 $52,189 - $67,584	-15,395 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$3.17 - $4.16 $8,891 - $11,668	-2,805 Reduced 15.41%	15,395 $59,000
Q3 2017 Nov 14, 2017	BUY	$3.03 - $3.97 $55,146 - $72,254	18,200	18,200 $66,000

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $61.1M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.